Target concentration intervention: Beyond Y2K

British Journal of Clinical Pharmacology

Volumn 52, Issue SUPPL. 1, 2001, Pages 55-59

  Holford, Nicholas H G ^a,b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Target concentration intervention; Therapeutic drug monitoring

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CYCLOSPORIN; DIGOXIN; PHENYTOIN; THEOPHYLLINE;

ALGORITHM; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG CONCENTRATION; DRUG DOSE; DRUG EFFECT; DRUG MONITORING; HUMAN; MODEL; PHARMACODYNAMICS; PHARMACOKINETICS; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VARIANCE;

EID: 0034845384     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2001.00971.x     Document Type: Article

References (23)

1. Therapeutic drug monitoring beyond 2000
2. Best practice in therapeutic drug monitoring
3. Therapeutic drug monitoring - Antiepileptic drugs
4. Therapeutic drug monitoring: Antiarrhythmic drugs
5. Therapeutic drug monitoring. The strategy of target concentration intervention
6. Clinical pharmacokinetics: The use of plasma concentrations of drugs
7. The clearance and volume method of dose prediction
8. Population models for Alzheimer's and Parkinson's disease
9. Theophylline target concentration in severe airways obstruction - 10 or 20 mg/L? A randomised concentration-controlled trial
10. Time and theophylline concentration help explain the recovery of peak flow following acute airways obstruction. Population analysis of a randomised concentration controlled trial
11. Understanding the dose-effect relationship: Clinical application of pharmacokinetic-pharmacodynamic models
12. Expanding clinical applications of population pharmacodynamic modelling
13. Automated covariate model building within NONMEM
14. The importance of modelling inter-occasion variability in population pharmacokinetic analyses
15. Comparison of drug dosing methods
16. Model-based, goal-oriented, individualised drug therapy. Linkage of population modelling, new 'multiple model' dosage design, bayesian feedback and individualised target goals
17. Target concentration strategy for cyclosporin monitoring
18. Therapeutic drug monitoring of immunosuppressant drugs
19. The therapeutic monitoring of antimicrobial agents
20. The randomized concentration-controlled trial: An evaluation of its sample size efficiency
21. Comparative efficiencies of randomized concentration- and dose-controlled clinical trials
22. Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia